The study demonstrated that 6‐thio‐dG potentiated antitumor immunity and reduced resistance to overcome PD‐L1 blockade resistance by simultaneously engaging innate and adaptive immunity in advanced cancers. The gene discussed is CD274; the disease is cancer.